会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 13. 发明授权
    • Method and system for determining pacing settings
    • 确定起搏设置的方法和系统
    • US09138583B2
    • 2015-09-22
    • US13596585
    • 2012-08-28
    • Nils HolmstromAndreas Karlsson
    • Nils HolmstromAndreas Karlsson
    • A61N1/362A61N1/365A61N1/37A61N1/368
    • A61N1/36585A61N1/365A61N1/36514A61N1/3682A61N1/3704
    • Systems and methods for optimizing the stimulation of a heart of a patient are disclosed herein. The method comprises delivering pacing therapy to the patient according to a pacing therapy setting schedule, using specific pacing intervals via specific electrode configurations. Further, sinus rate values are recorded over at least one cardiac cycle at each pacing therapy setting and it is determined whether a sinus rate value satisfies predetermined measurement conditions, wherein sinus rate values are used for trending the sinus rate over time if the measurement conditions are satisfied. The accepted sinus rate values, i.e. values that satisfy the measurement conditions, are trended over time, wherein each trended sinus rate value is created based on recordings from at least one cardiac cycle. A preferred pacing therapy setting is determined to be the pacing therapy setting that provides a lowest sinus rate.
    • 本文公开了用于优化患者心脏刺激的系统和方法。 该方法包括根据起搏治疗设置时间表,通过特定电极配置使用特定的起搏间隔向患者输送起搏治疗。 此外,在每个起搏治疗设置中,在至少一个心动周期上记录窦速率值,并且确定窦速率值是否满足预定的测量条件,其中如果测量条件是窦性速率值,则使用窦速率值来随着时间推移窦速率 满意。 接受的窦速率值,即满足测量条件的值随时间趋势,其中每个趋势窦速率值是基于至少一个心动周期的记录创建的。 优选的起搏治疗设置被确定为提供最低窦速率的起搏治疗设置。
    • 14. 发明申请
    • IMPLANTABLE HEART STIMULATION DEVICE WITH REMEDIAL RESPONSE TO ANODAL CAPTURE
    • 具有针对阳极捕获的补救措施的可植入心脏刺激装置
    • US20090030470A1
    • 2009-01-29
    • US12160849
    • 2006-01-26
    • Nils HolmstromAnders Bjorling
    • Nils HolmstromAnders Bjorling
    • A61N1/368
    • A61N1/371A61N1/3684
    • An implantable heart stimulating device has a left ventricular coronary sinus electrode lead provided with a tip electrode, a right ventricular electrode lead provided with a ring electrode, and a pulse generator connected to the leads that applies stimulation pulses between the tip electrode and the ring electrode, with the tip electrode serving as the anode. A monitoring unit monitors for and detects anodal capture at the right ventricular ring electrode subsequent to a stimulation. If anodal capture is detected, either a threshold search is performed by varying the pulse width and/or pulse amplitude of stimulation pulses in order to identify stimulation pulse characteristics that avoid anodal capture at the ring electrode, or at least one further electrode is activated to function as an indifferent electrode together with the ring electrode, also in order to avoid anodal capture at the ring electrode.
    • 可植入心脏刺激装置具有设置有尖端电极的左心室冠状窦电极引线,设置有环形电极的右心室电极引线和连接到引线的脉冲发生器,其在尖端电极和环形电极之间施加刺激脉冲 ,尖端电极用作阳极。 监测单元在刺激之后监测和检测右心室环电极处的阳极捕获。 如果检测到阳极捕获,则通过改变刺激脉冲的脉冲宽度和/或脉冲幅度来执行阈值搜索,以便识别避免在环形电极处的阳极捕获的刺激脉冲特性,或者至少一个另外的电极被激活 与环形电极一起作为无关电极,也是为了避免在环形电极处的阳极捕获。
    • 18. 发明申请
    • IMPLANTABLE MEDICAL DEVICE FOR CARDIAC THERAPY
    • 用于心脏治疗的可植入医疗器械
    • US20120239102A1
    • 2012-09-20
    • US13510873
    • 2009-12-08
    • Nils HolmstromJohn GustafssonMichael Broome
    • Nils HolmstromJohn GustafssonMichael Broome
    • A61N1/365A61N1/05A61N1/362
    • A61N1/368A61N1/3627A61N1/3684A61N2001/0585
    • An implantable medical device, IMD, (100) is connectable to at least one ventricular lead (210) having a ventricular basal electrode (214) and a ventricular apical electrode (212). The IMD (100) comprises a pulse generator (120) for generating pacing pulses applied to a heart (10) through the ventricular lead (210). The operation of this pulse generator (120) is controlled by a controller (130) that is configured to control the pulse generator to first deliver a pacing pulse to the ventricular basal electrode (214) to stimulate the basal portion of the ventricle (12, 14) before a pacing pulse is delivered to the apical portion of the ventricle (12, 14) by the ventricular apical electrode (212). This pulse sequence achieves a biologically more correct cardiac stimulation and a contraction pattern that reduces the risk for valvular regurgitation.
    • 植入式医疗装置IMD(100)可连接到至少一个具有心室基底电极(214)和心室顶端电极(212)的心室引线(210)。 IMD(100)包括用于产生通过心室引线(210)施加到心脏(10)的起搏脉冲的脉冲发生器(120)。 该脉冲发生器(120)的操作由控制器(130)控制,控制器(130)被配置为控制脉冲发生器首先将起搏脉冲递送至心室基底电极(214)以刺激心室的基部(12, 14)在通过心室顶端电极(212)将起搏脉冲输送到心室(12,14)的顶端部分之前。 该脉冲序列实现了生物学更正确的心脏刺激和减少瓣膜反流风险的收缩模式。